Browsing Tag
Marc Kikuchi
9 posts
Dr. Reddy’s Laboratories expands wellness portfolio with MenoLabs acquisition
In a significant move within the healthcare industry, Dr. Reddy’s Laboratories Ltd. has announced the acquisition of the…
Dr. Reddy’s Labs, Slayback sign licensing deal for Brimonidine Tartrate
Dr. Reddy’s Laboratories said that it has signed a licensing deal with New Jersey-based Slayback Pharma for acquiring…
Dr. Reddy’s Laboratories launches sorafenib generic in US
Dr. Reddy’s Laboratories said that it has launched Dr. Reddy’s Sorafenib Tablets, USP, 200 mg in the US…
Dr. Reddy’s, Senores launch Ketorolac Tromethamine Tablets in US
Dr. Reddy’s Laboratories and its partner Senores Pharmaceuticals have launched Ketorolac Tromethamine Tablets USP, 10 mg, in the…
Dr. Reddy’s Laboratories relaunches OTC Naproxen Sodium Tablets in US
Dr. Reddy’s Laboratories said that it has relaunched over-the-counter (OTC) Naproxen Sodium Tablets USP, 220 mg, the store-brand…
Dr. Reddy’s Laboratories launches Ertapenem for Injection in US
Dr. Reddy’s Laboratories has launched Ertapenem for Injection, 1 g/vial, a generic version of INVANZ (ertapenem for injection)…
Dr. Reddy’s Laboratories launches Sapropterin dihydrochloride powder in US
Dr. Reddy’s Laboratories has launched Sapropterin Dihydrochloride Powder for Oral Solution, 100mg, a generic of BioMarin’s Kuvan (sapropterin…
Dr. Reddy’s launches Sapropterin Dihydrochloride Tablets generic version in US
Indian pharma company Dr. Reddy’s Laboratories has launched a generic version of phenylalanine hydroxylase activator Sapropterin Dihydrochloride Tablets,…
Marc Kikuchi appointed CEO of Dr. Reddy’s North America Generics unit
Dr. Reddy’s Laboratories has announced the appointment of Marc Kikuchi as the CEO of its North America Generics…